1Division of Infectious Disease Response, Chungnam Regional Center for Disease Control and Prevention, Korea Disease Control and Prevention Agency, Daejeon, Republic of Korea
2Chungnam Center for Infectious Diseases Control and Prevention, Hongseong, Republic of Korea
3Division of Infectious Disease Control, Bureau of Infectious Disease Policy, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea
© 2023 Korea Disease Control and Prevention Agency.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Characteristic | Total | Infected | Uninfected | Attack rate (%) | p-value |
||
---|---|---|---|---|---|---|---|
Total | 602 (100.0) | 434 (100.0) | 168 (100.0) | 72.1 | |||
Sex | <0.001 | ||||||
Male | 240 (39.9) | 155 (35.7) | 85 (50.6) | 64.6 | |||
Female | 362 (60.1) | 279 (64.3) | 83 (49.4) | 77.1 | |||
Age (y) | 0.002 | ||||||
≤59 | 372 (61.8) | 252 (58.1) | 120 (71.4) | 67.7 | |||
60–69 | 129 (21.4) | 108 (24.9) | 21 (12.5) | 83.7 | |||
≥70 | 101 (16.8) | 74 (17.1) | 27 (16.1) | 73.3 | |||
Employment (n=429) |
<0.001 | ||||||
No | 266 (62.0) | 266 (65.8) | 0 (0.0) | 100 | |||
Yes | 163 (38.0) | 138 (34.2) | 25 (100.0) | 84.7 | |||
Residence (n=466) |
<0.001 | ||||||
<500 m | 220 (47.2) | 193 (52.7) | 27 (27.0) | 87.7 | |||
500–1,000 m | 208 (44.6) | 151 (41.3) | 57 (57.0) | 72.6 | |||
>1,000 m | 38 (8.2) | 22 (6.0) | 16 (16.0) | 57.9 | |||
Vaccination status | <0.001 | ||||||
Unvaccinated | 458 (76.1) | 374 (86.2) | 84 (50.0) | 81.7 | |||
1 dose | 9 (1.5) | 5 (1.2) | 4 (2.4) | 55.6 | |||
2 doses | 135 (22.4) | 55 (12.7) | 80 (47.6) | 40.7 | |||
Characteristic | n (%) | aORb) | 95% CI | p-value |
---|---|---|---|---|
Sex | 434 (100.0) | |||
Male | 155 (35.7) | Reference | 0.78–2.18 | 0.308 |
Female | 279 (64.3) | 1.31 | ||
Age (y) | 434 (100.0) | |||
≤59 | 252 (58.1) | Reference | ||
60-69 | 108 (24.9) | 6.23 | 2.66–14.59 | <0.001 |
≥70 | 74 (17.1) | 2.89 | 1.36–6.16 | 0.006 |
Residence (n=366) |
366 (100.0) | |||
<500 m | 193 (52.7) | 3.42 | 1.42–8.21 | 0.006 |
500–1,000 m | 151 (41.3) | 1.47 | 0.64–3.38 | 0.364 |
>1,000 m | 22 (6.0) | Reference | ||
Vaccination status | 434 (100.0) | |||
Unvaccinated | 374 (86.2) | 9.23 | 5.03–16.93 | <0.001 |
Vaccinated | 60 (13.8) | Reference |
Vaccination status | Total (n=602) | Infected (n=434) | VE (95% CI) | |||
---|---|---|---|---|---|---|
Unvaccinated | Vaccinated |
Unvaccinated | Vaccinated | |||
Sex | 458 (76.1) | 144 (23.9) | 374 (86.2) | 60 (13.8) | 49.0 (37.8–58.1) | |
Male | 164 (68.3) | 76 (31.7) | 123 (79.4) | 32 (20.6) | 43.9 (25.9–57.5) | |
Female | 294 (81.2) | 68 (18.8) | 251 (90.0) | 28 (10.0) | 51.8 (35.7–63.8) | |
Age (y) | 458 (76.1) | 144 (23.9) | 374 (86.2) | 60 (13.8) | 49.0 (37.8–58.1) | |
≤59 | 307 (82.5) | 65 (17.5) | 235 (93.3) | 17 (6.7) | 65.8 (48.3–77.4) | |
60–69 | 86 (66.7) | 43 (33.3) | 83 (76.9) | 25 (23.1) | 39.8 (22.1–53.4) | |
≥70 | 65 (64.4) | 36 (35.6) | 56 (75.7) | 18 (24.3) | 42.0 (18.4–58.7) | |
Occupation |
361 (84.1) | 68 (15.9) | 349 (86.4) | 55 (13.6) | 16.3 (5.9–25.6) | |
No | 228 (85.7) | 38 (14.3) | 228 (85.7) | 38 (14.3) | - | |
Yes | 133 (81.6) | 30 (18.4) | 121 (87.7) | 17 (12.3) | 37.7 (14.4–54.7) | |
Residence |
373 (80.0) | 93 (20.0) | 321 (87.7) | 45 (12.3) | 43.8 (30.4–46.0) | |
<500 m | 186 (84.5) | 34 (15.5) | 166 (86.0) | 27 (14.0) | 11.0 (-63.0–25.5) | |
500–1,000 m | 162 (77.9) | 46 (22.1) | 136 (90.1) | 15 (9.9.) | 61.2 (42.8–74.4) | |
>1,000 m | 25 (65.8) | 13 (34.2) | 19 (86.4) | 3 (13.6) | 69.6 (16.1–89.0) |
Data are presented as Determined using the chi-square test, unless otherwise specified. People whose occupation was not confirmed were excluded ( Registered people in other regions were excluded based on their residence listed in the resident registration (
aOR, adjusted odds ratio; CI, confidence interval. Registered people in other regions were excluded based on their residence listed in the resident registration ( Odds ratios were calculated by logistic regression after adjustment for sex, age, residence, and vaccination state.
aOR, adjusted odds ratio; CI, confidence interval. Vaccinated: Those for whom 14 days had passed since receiving the second dose. People whose occupation was not confirmed were excluded ( Registered people in other regions were excluded based on their residence listed in the resident registration (